An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression-Reference-Cited by-同舟云学术

An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression

Published:2021-02-18 Issue: Volume: Page:
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Tanana Laila¹,Latif Asam²,Nishtala Prasad S.³,Taylor David⁴,Chen Timothy F.¹

Affiliation:

1. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

2. School of Health Sciences, Faculty of Medicine and Health Sciences, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.

3. Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom.

4. Maudsley Hospital, London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2020.0154

Reference33 articles.

1. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation

2. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012

3. Information for Adequate Prescribing to Older Patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Variations in Medicine Approvals for Attention-Deficit/Hyperactivity Disorder: A Cross-Country Document Analysis Comparing Drug Labeling;Journal of Attention Disorders;2024-02-07

2. Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016;European Neuropsychopharmacology;2022-12